GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smad1
|
ENSRNOG00000018483 | SMAD family member 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Smad1 | rn6_v1_chr19_+_32188267_32188267 | -0.30 | 3.1e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_219329574 | 125.69 |
ENSRNOT00000071109
|
Cabp2
|
calcium binding protein 2 |
chr7_-_71226150 | 99.16 |
ENSRNOT00000005875
|
RGD1561812
|
similar to Retinol dehydrogenase type II (RODH II) (29 k-protein) |
chr1_+_83711251 | 90.25 |
ENSRNOT00000028237
ENSRNOT00000092008 |
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr6_+_127946686 | 82.42 |
ENSRNOT00000082680
|
LOC500712
|
Ab1-233 |
chr16_-_56900052 | 77.79 |
ENSRNOT00000017339
|
Msr1
|
macrophage scavenger receptor 1 |
chr3_-_7141522 | 74.32 |
ENSRNOT00000014572
|
Cel
|
carboxyl ester lipase |
chr19_-_64303 | 67.27 |
ENSRNOT00000015451
|
Ces2a
|
carboxylesterase 2A |
chr2_+_186685104 | 65.06 |
ENSRNOT00000057022
|
Cd5l
|
Cd5 molecule-like |
chr3_-_2853272 | 64.40 |
ENSRNOT00000023022
|
Fcna
|
ficolin A |
chr5_-_78985990 | 64.18 |
ENSRNOT00000009248
|
Ambp
|
alpha-1-microglobulin/bikunin precursor |
chr11_-_81444375 | 63.71 |
ENSRNOT00000058479
ENSRNOT00000078131 ENSRNOT00000080949 ENSRNOT00000080562 ENSRNOT00000084867 |
Kng1
|
kininogen 1 |
chr2_-_216443518 | 63.14 |
ENSRNOT00000022496
|
Amy1a
|
amylase, alpha 1A |
chr6_-_128003418 | 56.24 |
ENSRNOT00000013896
|
Serpina3c
|
serine (or cysteine) proteinase inhibitor, clade A, member 3C |
chr8_+_50525091 | 53.54 |
ENSRNOT00000074357
|
Apoa1
|
apolipoprotein A1 |
chr3_-_80543031 | 51.93 |
ENSRNOT00000022233
|
F2
|
coagulation factor II |
chr16_-_7007051 | 51.75 |
ENSRNOT00000023984
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr14_-_19191863 | 51.58 |
ENSRNOT00000003921
|
Alb
|
albumin |
chr4_+_70776046 | 51.42 |
ENSRNOT00000040403
|
Prss1
|
protease, serine 1 |
chr7_+_71057911 | 50.81 |
ENSRNOT00000037218
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr1_-_48563776 | 50.71 |
ENSRNOT00000023368
|
Plg
|
plasminogen |
chr4_+_153921115 | 49.89 |
ENSRNOT00000018821
|
Slc6a12
|
solute carrier family 6 member 12 |
chr7_+_70980422 | 49.80 |
ENSRNOT00000077912
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr4_+_57952982 | 49.55 |
ENSRNOT00000014465
|
Cpa1
|
carboxypeptidase A1 |
chr1_+_189364288 | 48.67 |
ENSRNOT00000080338
|
Acsm1
|
acyl-CoA synthetase medium-chain family member 1 |
chr4_+_154505826 | 48.51 |
ENSRNOT00000044408
|
Mug1
|
murinoglobulin 1 |
chr11_+_74057361 | 47.52 |
ENSRNOT00000048746
|
Cpn2
|
carboxypeptidase N subunit 2 |
chr11_-_81735592 | 47.12 |
ENSRNOT00000078203
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr8_-_50539331 | 47.08 |
ENSRNOT00000088997
|
AABR07073400.1
|
|
chr4_+_154391647 | 46.82 |
ENSRNOT00000081488
ENSRNOT00000079192 |
Mug1
|
murinoglobulin 1 |
chr1_+_83933942 | 46.72 |
ENSRNOT00000068690
|
Cyp2f4
|
cytochrome P450, family 2, subfamily f, polypeptide 4 |
chr4_+_109497962 | 46.24 |
ENSRNOT00000057869
|
Reg1a
|
regenerating family member 1 alpha |
chr1_+_279867034 | 46.09 |
ENSRNOT00000024164
|
Pnliprp1
|
pancreatic lipase-related protein 1 |
chr9_+_9721105 | 45.85 |
ENSRNOT00000073042
ENSRNOT00000075494 |
C3
|
complement C3 |
chr19_+_85606 | 45.49 |
ENSRNOT00000015724
|
Ces2e
|
carboxylesterase 2E |
chr6_-_127656603 | 45.27 |
ENSRNOT00000015516
|
Serpina11
|
serpin family A member 11 |
chr20_-_5805627 | 44.09 |
ENSRNOT00000085996
|
Clps
|
colipase |
chr13_+_50164563 | 42.78 |
ENSRNOT00000029533
|
Lax1
|
lymphocyte transmembrane adaptor 1 |
chr16_+_18690649 | 42.24 |
ENSRNOT00000015190
|
Mat1a
|
methionine adenosyltransferase 1A |
chr14_+_20266891 | 41.94 |
ENSRNOT00000004174
|
Gc
|
group specific component |
chr1_-_73660593 | 41.57 |
ENSRNOT00000038802
|
Lilra5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
chr7_+_71065197 | 40.90 |
ENSRNOT00000051075
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr10_+_56710965 | 40.77 |
ENSRNOT00000087121
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr20_-_2678141 | 40.53 |
ENSRNOT00000072377
ENSRNOT00000083833 |
C4a
|
complement component 4A (Rodgers blood group) |
chr8_+_50559126 | 40.46 |
ENSRNOT00000024918
|
Apoa5
|
apolipoprotein A5 |
chr4_+_98457810 | 40.22 |
ENSRNOT00000074175
|
AABR07060872.1
|
|
chr19_+_15294248 | 40.19 |
ENSRNOT00000024622
|
Ces1f
|
carboxylesterase 1F |
chr1_-_259287684 | 39.98 |
ENSRNOT00000054724
|
Cyp2c22
|
cytochrome P450, family 2, subfamily c, polypeptide 22 |
chr4_+_154676427 | 39.57 |
ENSRNOT00000019969
ENSRNOT00000087441 |
Mug1
|
murinoglobulin 1 |
chr16_+_6970342 | 39.38 |
ENSRNOT00000061294
ENSRNOT00000048344 |
Itih4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr6_+_132762280 | 39.31 |
ENSRNOT00000004070
|
Slc25a47
|
solute carrier family 25, member 47 |
chr10_-_70802782 | 39.23 |
ENSRNOT00000045867
|
Ccl6
|
chemokine (C-C motif) ligand 6 |
chr8_+_50537009 | 38.85 |
ENSRNOT00000080658
|
Apoa4
|
apolipoprotein A4 |
chr4_+_70614524 | 38.73 |
ENSRNOT00000041100
|
Prss3
|
protease, serine 3 |
chr10_-_66229311 | 38.21 |
ENSRNOT00000016897
|
Lgals5
|
lectin, galactose binding, soluble 5 |
chr7_-_123621102 | 37.84 |
ENSRNOT00000046024
|
Cyp2d5
|
cytochrome P450, family 2, subfamily d, polypeptide 5 |
chr14_+_22937421 | 37.65 |
ENSRNOT00000065079
|
RGD1559459
|
similar to Expressed sequence AI788959 |
chr1_-_170431073 | 37.58 |
ENSRNOT00000024710
|
Hpx
|
hemopexin |
chr6_-_139997537 | 37.51 |
ENSRNOT00000073207
|
AABR07065740.1
|
|
chr1_+_201672528 | 37.45 |
ENSRNOT00000093490
|
Dmbt1
|
deleted in malignant brain tumors 1 |
chr7_+_3216497 | 37.31 |
ENSRNOT00000008909
|
Mmp19
|
matrix metallopeptidase 19 |
chr16_-_7026540 | 37.06 |
ENSRNOT00000051751
|
Itih1
|
inter-alpha trypsin inhibitor, heavy chain 1 |
chr7_-_119689938 | 36.88 |
ENSRNOT00000000200
|
Tmprss6
|
transmembrane protease, serine 6 |
chr4_-_103258134 | 36.37 |
ENSRNOT00000086827
|
AABR07061052.1
|
|
chr14_+_22251499 | 36.34 |
ENSRNOT00000087991
ENSRNOT00000002705 |
Ugt2a1
|
UDP glucuronosyltransferase 2 family, polypeptide A1 |
chr3_-_14112851 | 36.24 |
ENSRNOT00000092736
|
C5
|
complement C5 |
chr9_+_74124016 | 36.22 |
ENSRNOT00000019023
|
Cps1
|
carbamoyl-phosphate synthase 1 |
chr15_-_42693694 | 36.06 |
ENSRNOT00000022702
|
Gulo
|
gulonolactone (L-) oxidase |
chr12_-_20276121 | 35.66 |
ENSRNOT00000065873
|
LOC685157
|
similar to paired immunoglobin-like type 2 receptor beta |
chr1_-_80609836 | 35.64 |
ENSRNOT00000091647
ENSRNOT00000046169 |
Apoc1
|
apolipoprotein C1 |
chr4_-_70628470 | 35.28 |
ENSRNOT00000029319
|
Try5
|
trypsin 5 |
chr17_-_69711689 | 34.81 |
ENSRNOT00000041925
|
Akr1c12
|
aldo-keto reductase family 1, member C12 |
chr1_+_213577122 | 34.56 |
ENSRNOT00000071925
|
RGD1309350
|
similar to transthyretin (4L369) |
chr6_-_127632265 | 34.49 |
ENSRNOT00000084157
|
Serpina1
|
serpin family A member 1 |
chr3_-_17081510 | 34.04 |
ENSRNOT00000063862
|
AABR07051562.1
|
|
chr4_-_157154120 | 33.86 |
ENSRNOT00000056058
|
C1s
|
complement C1s |
chr20_+_295250 | 33.86 |
ENSRNOT00000000955
|
Clic2
|
chloride intracellular channel 2 |
chr4_+_98370797 | 33.60 |
ENSRNOT00000031991
|
AABR07060872.1
|
|
chr7_+_14891001 | 33.41 |
ENSRNOT00000041034
|
Cyp4f4
|
cytochrome P450, family 4, subfamily f, polypeptide 4 |
chr16_+_18690246 | 33.35 |
ENSRNOT00000081484
|
Mat1a
|
methionine adenosyltransferase 1A |
chr9_+_100281339 | 33.34 |
ENSRNOT00000029127
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr2_+_55775274 | 33.07 |
ENSRNOT00000018545
|
C9
|
complement C9 |
chr6_-_7961207 | 32.93 |
ENSRNOT00000007174
|
Abcg5
|
ATP binding cassette subfamily G member 5 |
chr1_+_65576535 | 32.76 |
ENSRNOT00000026575
|
Slc27a5
|
solute carrier family 27 member 5 |
chr4_+_99063181 | 32.64 |
ENSRNOT00000008840
|
Fabp1
|
fatty acid binding protein 1 |
chr7_-_123630045 | 32.52 |
ENSRNOT00000050002
|
Cyp2d1
|
cytochrome P450, family 2, subfamily d, polypeptide 1 |
chr8_-_62458301 | 32.25 |
ENSRNOT00000021653
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr1_-_80599572 | 31.98 |
ENSRNOT00000024832
|
Apoc4
|
apolipoprotein C4 |
chr14_+_22724070 | 31.65 |
ENSRNOT00000089471
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr4_+_98371184 | 31.41 |
ENSRNOT00000086911
|
AABR07060872.1
|
|
chr5_-_155772040 | 31.30 |
ENSRNOT00000036788
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr19_+_15143794 | 31.23 |
ENSRNOT00000085762
|
Ces1f
|
carboxylesterase 1F |
chr20_-_30947484 | 31.04 |
ENSRNOT00000065614
|
Pald1
|
phosphatase domain containing, paladin 1 |
chr16_-_7007287 | 30.65 |
ENSRNOT00000041216
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr10_+_56710464 | 30.46 |
ENSRNOT00000065370
ENSRNOT00000064064 |
Asgr2
|
asialoglycoprotein receptor 2 |
chr20_-_4316715 | 30.38 |
ENSRNOT00000031704
|
C4b
|
complement C4B (Chido blood group) |
chr4_+_154215250 | 30.35 |
ENSRNOT00000072465
|
Mug2
|
murinoglobulin 2 |
chr10_-_98544447 | 30.16 |
ENSRNOT00000073149
|
Abca6
|
ATP binding cassette subfamily A member 6 |
chr8_-_111761871 | 30.13 |
ENSRNOT00000056483
|
RGD1310507
|
similar to RIKEN cDNA 1300017J02 |
chr18_+_12008759 | 30.04 |
ENSRNOT00000022665
ENSRNOT00000061344 ENSRNOT00000038635 |
Dsg1
|
desmoglein 1 |
chr11_+_80736576 | 29.97 |
ENSRNOT00000047678
|
Masp1
|
mannan-binding lectin serine peptidase 1 |
chr3_+_95233874 | 29.96 |
ENSRNOT00000079743
|
LOC691083
|
hypothetical protein LOC691083 |
chr20_-_5806097 | 29.89 |
ENSRNOT00000000611
|
Clps
|
colipase |
chr7_+_2689501 | 29.86 |
ENSRNOT00000041341
|
Apof
|
apolipoprotein F |
chr7_-_27552078 | 29.55 |
ENSRNOT00000059538
|
Stab2
|
stabilin 2 |
chr11_-_87924816 | 29.54 |
ENSRNOT00000031819
|
Serpind1
|
serpin family D member 1 |
chr10_+_14240219 | 29.40 |
ENSRNOT00000020233
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr14_-_80973456 | 29.34 |
ENSRNOT00000013257
|
Hgfac
|
HGF activator |
chr12_+_12227010 | 29.29 |
ENSRNOT00000060843
ENSRNOT00000092610 |
Baiap2l1
|
BAI1-associated protein 2-like 1 |
chr9_+_100156154 | 29.20 |
ENSRNOT00000005935
|
Aqp12a
|
aquaporin 12A |
chr15_+_27875911 | 29.09 |
ENSRNOT00000013582
|
Pnp
|
purine nucleoside phosphorylase |
chr4_-_78458179 | 29.07 |
ENSRNOT00000078473
ENSRNOT00000011327 |
Tmem176b
|
transmembrane protein 176B |
chr6_-_138744480 | 28.75 |
ENSRNOT00000089387
|
AABR07065651.5
|
|
chr19_+_42097995 | 28.72 |
ENSRNOT00000020197
|
Hp
|
haptoglobin |
chr10_-_38774449 | 28.61 |
ENSRNOT00000049820
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr10_+_92667869 | 28.60 |
ENSRNOT00000082780
ENSRNOT00000073350 |
Itgb3
|
integrin subunit beta 3 |
chr2_+_182006242 | 28.57 |
ENSRNOT00000064091
|
Fga
|
fibrinogen alpha chain |
chr16_-_85135859 | 28.20 |
ENSRNOT00000075773
|
Marco
|
macrophage receptor with collagenous structure |
chr16_-_81834945 | 28.17 |
ENSRNOT00000037806
|
F7
|
coagulation factor VII |
chr7_+_99158119 | 28.14 |
ENSRNOT00000044127
|
LOC108348266
|
cytochrome P450 2B1 |
chr1_+_248723397 | 27.64 |
ENSRNOT00000072188
|
LOC100911854
|
mannose-binding protein C-like |
chr3_-_2719135 | 27.51 |
ENSRNOT00000080257
|
Lcn12
|
lipocalin 12 |
chr7_+_143754892 | 27.47 |
ENSRNOT00000085896
|
Soat2
|
sterol O-acyltransferase 2 |
chr15_-_28081465 | 27.43 |
ENSRNOT00000033739
|
Rnase6
|
ribonuclease, RNase A family, 6 |
chr10_-_19574094 | 27.40 |
ENSRNOT00000059810
|
Dock2
|
dedicator of cytokinesis 2 |
chr1_+_166478005 | 27.27 |
ENSRNOT00000030037
|
Arap1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr2_-_210703606 | 27.21 |
ENSRNOT00000077563
|
Gstm6l
|
glutathione S-transferase, mu 6-like |
chr3_+_16846412 | 27.11 |
ENSRNOT00000074266
|
AABR07051551.1
|
|
chr1_-_198104109 | 27.06 |
ENSRNOT00000026186
|
Sult1a1
|
sulfotransferase family 1A member 1 |
chr7_-_119712888 | 27.02 |
ENSRNOT00000077438
|
Il2rb
|
interleukin 2 receptor subunit beta |
chr5_-_19368431 | 26.77 |
ENSRNOT00000012819
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chr1_+_216677373 | 26.70 |
ENSRNOT00000027925
|
Slc22a18
|
solute carrier family 22, member 18 |
chr7_+_118685022 | 26.64 |
ENSRNOT00000089135
|
Apol3
|
apolipoprotein L, 3 |
chr1_+_64506735 | 26.60 |
ENSRNOT00000086331
|
Nlrp12
|
NLR family, pyrin domain containing 12 |
chr9_+_46997798 | 26.50 |
ENSRNOT00000087112
ENSRNOT00000082408 |
Il1r1
|
interleukin 1 receptor type 1 |
chr1_-_48559162 | 26.43 |
ENSRNOT00000080352
|
Plg
|
plasminogen |
chr19_+_50246402 | 26.41 |
ENSRNOT00000018795
|
Hsd17b2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
chr6_-_139142218 | 26.38 |
ENSRNOT00000006975
|
Ighg
|
Immunoglobulin heavy chain (gamma polypeptide) |
chr5_+_133620706 | 26.27 |
ENSRNOT00000053202
|
Gm12830
|
predicted gene 12830 |
chr1_+_173252058 | 26.21 |
ENSRNOT00000073421
|
LOC499229
|
similar to very large inducible GTPase 1 isoform A |
chr2_-_196113149 | 26.19 |
ENSRNOT00000088465
|
Selenbp1
|
selenium binding protein 1 |
chr6_+_139486775 | 26.01 |
ENSRNOT00000077771
|
AABR07065699.3
|
|
chr1_+_279798187 | 25.97 |
ENSRNOT00000024065
|
Pnlip
|
pancreatic lipase |
chr8_-_23146689 | 25.91 |
ENSRNOT00000092200
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr1_-_224389389 | 25.84 |
ENSRNOT00000077408
ENSRNOT00000050010 |
UST4r
|
integral membrane transport protein UST4r |
chr17_-_8429338 | 25.83 |
ENSRNOT00000016390
|
Tgfbi
|
transforming growth factor, beta induced |
chr12_-_21362205 | 25.71 |
ENSRNOT00000064787
|
LOC108348155
|
paired immunoglobulin-like type 2 receptor beta-2 |
chr9_+_95202632 | 25.65 |
ENSRNOT00000025652
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr10_+_103562725 | 25.56 |
ENSRNOT00000075199
|
AABR07030773.1
|
|
chr12_-_21670269 | 25.46 |
ENSRNOT00000074863
|
LOC100910801
|
paired immunoglobulin-like type 2 receptor alpha-like |
chr1_+_193424812 | 25.35 |
ENSRNOT00000019939
|
Aqp8
|
aquaporin 8 |
chr20_-_27782586 | 25.33 |
ENSRNOT00000001093
|
Dse
|
dermatan sulfate epimerase |
chr1_+_80880856 | 25.22 |
ENSRNOT00000026060
|
Ceacam20
|
carcinoembryonic antigen-related cell adhesion molecule 20 |
chr6_-_138507294 | 25.18 |
ENSRNOT00000078516
|
AABR07065640.1
|
|
chr13_+_99335020 | 25.17 |
ENSRNOT00000029787
|
AABR07021930.1
|
|
chr7_-_123655896 | 25.13 |
ENSRNOT00000012413
|
Cyp2d2
|
cytochrome P450, family 2, subfamily d, polypeptide 2 |
chr6_-_7058314 | 25.00 |
ENSRNOT00000045996
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr7_-_117679219 | 24.97 |
ENSRNOT00000071522
|
Slc39a4
|
solute carrier family 39 member 4 |
chr7_-_142318620 | 24.94 |
ENSRNOT00000006351
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr12_-_21923281 | 24.91 |
ENSRNOT00000075641
|
RGD1561143
|
similar to cell surface receptor FDFACT |
chr20_+_3990820 | 24.74 |
ENSRNOT00000000528
|
Psmb8
|
proteasome subunit beta 8 |
chr14_+_22724399 | 24.64 |
ENSRNOT00000002724
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr6_-_138321002 | 24.55 |
ENSRNOT00000056845
|
Ighm
|
immunoglobulin heavy constant mu |
chr1_+_250426158 | 24.51 |
ENSRNOT00000067643
|
A1cf
|
APOBEC1 complementation factor |
chr3_-_2727616 | 24.38 |
ENSRNOT00000061904
|
C8g
|
complement C8 gamma chain |
chr11_-_34142753 | 24.38 |
ENSRNOT00000002297
|
Cldn14
|
claudin 14 |
chr7_-_34406318 | 24.27 |
ENSRNOT00000007331
|
Amdhd1
|
amidohydrolase domain containing 1 |
chr10_+_90085559 | 24.26 |
ENSRNOT00000028332
|
Nags
|
N-acetylglutamate synthase |
chr7_+_118692851 | 24.25 |
ENSRNOT00000091911
|
LOC100911562
|
apolipoprotein L3-like |
chr17_-_28191436 | 24.24 |
ENSRNOT00000000149
|
Ly86
|
lymphocyte antigen 86 |
chr2_+_186703541 | 24.11 |
ENSRNOT00000093342
|
Fcrl1
|
Fc receptor-like 1 |
chr3_-_16753987 | 24.10 |
ENSRNOT00000091257
|
AABR07051548.1
|
|
chr3_-_72171078 | 24.09 |
ENSRNOT00000009817
|
Serping1
|
serpin family G member 1 |
chr2_+_54466280 | 24.00 |
ENSRNOT00000033112
|
C6
|
complement C6 |
chr15_+_57290849 | 23.89 |
ENSRNOT00000014909
|
Cpb2
|
carboxypeptidase B2 |
chr4_+_172119331 | 23.78 |
ENSRNOT00000010579
|
Mgst1
|
microsomal glutathione S-transferase 1 |
chr17_-_31706523 | 23.76 |
ENSRNOT00000071312
|
AABR07027447.1
|
|
chr12_-_21832813 | 23.71 |
ENSRNOT00000075280
|
Cldn3
|
claudin 3 |
chr6_-_141147264 | 23.67 |
ENSRNOT00000042900
|
LOC100361105
|
Igh protein-like |
chr20_+_13799102 | 23.62 |
ENSRNOT00000001669
|
Gstt1
|
glutathione S-transferase theta 1 |
chr7_-_67345295 | 23.46 |
ENSRNOT00000087045
ENSRNOT00000005829 |
Avpr1a
|
arginine vasopressin receptor 1A |
chr17_+_78793336 | 23.46 |
ENSRNOT00000057898
|
Mt1
|
metallothionein 1 |
chr12_+_36734372 | 23.37 |
ENSRNOT00000001301
|
Scarb1
|
scavenger receptor class B, member 1 |
chr16_-_81822716 | 23.30 |
ENSRNOT00000026677
|
F10
|
coagulation factor X |
chr4_+_175814118 | 23.28 |
ENSRNOT00000013409
ENSRNOT00000013514 |
Slco1b2
|
solute carrier organic anion transporter family, member 1B2 |
chr17_+_30965942 | 23.20 |
ENSRNOT00000060143
|
Pxdc1
|
PX domain containing 1 |
chr2_-_210703265 | 23.12 |
ENSRNOT00000080228
|
Gstm6l
|
glutathione S-transferase, mu 6-like |
chr6_-_140102325 | 23.04 |
ENSRNOT00000072238
|
AABR07065750.2
|
|
chr20_-_2652952 | 23.00 |
ENSRNOT00000078871
|
C4a
|
complement component 4A (Rodgers blood group) |
chr20_-_11546046 | 22.97 |
ENSRNOT00000068374
|
LOC690386
|
hypothetical protein LOC690386 |
chr1_+_83653234 | 22.96 |
ENSRNOT00000085008
ENSRNOT00000084230 ENSRNOT00000090071 |
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr2_+_227455722 | 22.87 |
ENSRNOT00000064809
|
Sec24d
|
SEC24 homolog D, COPII coat complex component |
chr4_-_157155609 | 22.85 |
ENSRNOT00000016330
|
C1s
|
complement C1s |
chr14_+_91782354 | 22.67 |
ENSRNOT00000005902
|
Ikzf1
|
IKAROS family zinc finger 1 |
chr1_+_83744238 | 22.65 |
ENSRNOT00000028249
|
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr1_+_199248470 | 22.61 |
ENSRNOT00000025933
|
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr4_-_115332052 | 22.61 |
ENSRNOT00000017643
|
Clec4f
|
C-type lectin domain family 4, member F |
chr7_-_102298522 | 22.60 |
ENSRNOT00000006273
|
A1bg
|
alpha-1-B glycoprotein |
chr6_-_139102378 | 22.59 |
ENSRNOT00000086423
|
AABR07065656.5
|
|
chr12_+_19714324 | 22.55 |
ENSRNOT00000072303
|
RGD1559588
|
similar to cell surface receptor FDFACT |
chr9_+_95295701 | 22.48 |
ENSRNOT00000025045
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.2 | 78.7 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
25.7 | 77.1 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
23.5 | 94.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
23.4 | 70.3 | GO:0042197 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
23.3 | 69.9 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
21.7 | 152.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
21.4 | 149.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
17.8 | 53.5 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
16.7 | 83.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
16.5 | 65.9 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
16.1 | 64.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
16.0 | 63.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
15.6 | 46.7 | GO:0060101 | negative regulation of phagocytosis, engulfment(GO:0060101) |
14.4 | 28.7 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
14.2 | 42.6 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
13.9 | 69.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
13.9 | 41.6 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
13.7 | 41.1 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) formamide metabolic process(GO:0043606) |
13.1 | 52.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
13.0 | 26.0 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
12.9 | 154.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
12.9 | 38.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
12.5 | 49.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
12.1 | 36.2 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
11.8 | 35.5 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
11.6 | 23.3 | GO:0046687 | response to chromate(GO:0046687) |
11.5 | 34.5 | GO:0033986 | response to methanol(GO:0033986) |
11.4 | 45.6 | GO:0042853 | L-alanine catabolic process(GO:0042853) |
11.4 | 136.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
11.2 | 33.5 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
11.1 | 111.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
11.0 | 22.1 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
10.9 | 32.6 | GO:0051977 | lysophospholipid transport(GO:0051977) |
10.8 | 53.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
10.7 | 53.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
10.7 | 42.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
10.7 | 10.7 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
10.6 | 42.4 | GO:0015879 | carnitine transport(GO:0015879) |
10.6 | 42.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
10.1 | 100.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
10.1 | 30.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
9.7 | 29.1 | GO:0034418 | nicotinamide riboside catabolic process(GO:0006738) urate biosynthetic process(GO:0034418) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
9.6 | 57.4 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
9.4 | 18.8 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
9.3 | 9.3 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
9.1 | 82.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
9.1 | 27.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
9.1 | 9.1 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
9.0 | 17.9 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
9.0 | 44.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
8.9 | 44.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
8.9 | 17.7 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
8.8 | 123.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
8.7 | 26.0 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
8.5 | 25.6 | GO:0003285 | septum secundum development(GO:0003285) |
8.5 | 42.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
8.4 | 33.4 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
8.2 | 24.6 | GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
8.2 | 16.4 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
8.1 | 16.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
8.1 | 24.3 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
8.1 | 32.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
8.0 | 31.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
8.0 | 23.9 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
7.9 | 23.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
7.8 | 23.5 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
7.8 | 23.5 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
7.7 | 7.7 | GO:0034014 | response to triglyceride(GO:0034014) |
7.7 | 23.0 | GO:1990743 | protein sialylation(GO:1990743) |
7.6 | 7.6 | GO:0046618 | drug export(GO:0046618) |
7.6 | 15.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
7.5 | 22.6 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
7.5 | 22.5 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
7.4 | 22.3 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
7.4 | 29.7 | GO:0006565 | L-serine catabolic process(GO:0006565) |
7.4 | 37.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
7.3 | 21.9 | GO:0010037 | response to carbon dioxide(GO:0010037) |
7.3 | 29.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
7.2 | 36.1 | GO:0009115 | xanthine catabolic process(GO:0009115) |
7.1 | 14.2 | GO:0010034 | response to acetate(GO:0010034) |
7.1 | 21.2 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
7.0 | 42.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
7.0 | 21.1 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
7.0 | 21.0 | GO:1903769 | negative regulation of cell proliferation in bone marrow(GO:1903769) negative regulation of immunological synapse formation(GO:2000521) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
6.9 | 6.9 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
6.8 | 27.2 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
6.7 | 13.5 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
6.7 | 336.0 | GO:0006953 | acute-phase response(GO:0006953) |
6.6 | 39.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
6.6 | 26.2 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
6.5 | 32.4 | GO:0009608 | response to symbiont(GO:0009608) |
6.2 | 18.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
6.2 | 18.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
6.2 | 61.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
6.0 | 18.1 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
6.0 | 17.9 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
6.0 | 23.9 | GO:0052695 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
5.9 | 29.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
5.9 | 41.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
5.9 | 11.8 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
5.8 | 23.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
5.7 | 11.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
5.7 | 22.8 | GO:0019477 | lysine catabolic process(GO:0006554) L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
5.7 | 45.5 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
5.6 | 16.8 | GO:0034769 | basement membrane disassembly(GO:0034769) |
5.5 | 16.4 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
5.4 | 16.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
5.4 | 16.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
5.4 | 21.4 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
5.3 | 16.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
5.3 | 15.9 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
5.3 | 10.5 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
5.2 | 15.7 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
5.1 | 5.1 | GO:2000464 | positive regulation of astrocyte chemotaxis(GO:2000464) |
5.1 | 25.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
5.0 | 20.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
5.0 | 10.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
5.0 | 29.8 | GO:0008228 | opsonization(GO:0008228) |
4.9 | 14.8 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
4.9 | 48.7 | GO:0032782 | bile acid secretion(GO:0032782) |
4.8 | 19.3 | GO:0030221 | basophil differentiation(GO:0030221) |
4.8 | 9.5 | GO:0044107 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
4.7 | 18.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
4.7 | 18.7 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
4.7 | 18.6 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
4.6 | 13.7 | GO:0006116 | NADH oxidation(GO:0006116) |
4.6 | 13.7 | GO:0061744 | motor behavior(GO:0061744) |
4.5 | 49.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
4.5 | 13.6 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
4.5 | 27.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
4.5 | 13.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
4.4 | 13.3 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
4.4 | 17.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
4.3 | 21.7 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
4.3 | 56.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
4.3 | 77.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
4.3 | 8.6 | GO:0046967 | cytosol to ER transport(GO:0046967) peptide antigen transport(GO:0046968) |
4.2 | 12.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
4.2 | 8.4 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
4.2 | 16.8 | GO:0034201 | response to oleic acid(GO:0034201) |
4.2 | 8.4 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
4.2 | 25.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
4.1 | 16.5 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
4.1 | 8.2 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
4.1 | 16.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
4.0 | 121.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
4.0 | 20.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
4.0 | 19.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.9 | 7.8 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
3.9 | 15.6 | GO:0061017 | hepatoblast differentiation(GO:0061017) |
3.9 | 50.8 | GO:0042730 | fibrinolysis(GO:0042730) |
3.9 | 46.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
3.9 | 15.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
3.8 | 7.7 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
3.8 | 26.9 | GO:0007144 | female meiosis I(GO:0007144) |
3.8 | 7.5 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
3.8 | 11.3 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
3.8 | 11.3 | GO:0002215 | defense response to nematode(GO:0002215) |
3.7 | 18.6 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
3.7 | 11.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
3.7 | 22.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
3.7 | 33.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
3.7 | 7.4 | GO:0042531 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
3.7 | 11.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
3.7 | 54.9 | GO:0015671 | oxygen transport(GO:0015671) |
3.7 | 11.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
3.6 | 7.3 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
3.6 | 10.9 | GO:1900368 | regulation of RNA interference(GO:1900368) |
3.6 | 10.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.6 | 10.9 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
3.6 | 7.2 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
3.6 | 7.2 | GO:0006548 | histidine catabolic process(GO:0006548) |
3.5 | 7.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
3.5 | 6.9 | GO:0060460 | left lung morphogenesis(GO:0060460) |
3.4 | 10.3 | GO:0046127 | thymidine catabolic process(GO:0006214) pyrimidine deoxyribonucleoside catabolic process(GO:0046127) |
3.4 | 65.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
3.4 | 17.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
3.4 | 10.1 | GO:1902103 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
3.4 | 10.1 | GO:0046865 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
3.4 | 10.1 | GO:0060764 | cell-cell signaling involved in mammary gland development(GO:0060764) |
3.3 | 10.0 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) N-acetylneuraminate biosynthetic process(GO:0046380) |
3.3 | 76.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
3.3 | 3.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
3.3 | 13.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
3.3 | 6.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
3.3 | 42.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
3.3 | 9.8 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
3.3 | 9.8 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
3.3 | 29.4 | GO:0034312 | diol biosynthetic process(GO:0034312) |
3.3 | 13.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
3.2 | 3.2 | GO:0010266 | response to vitamin B1(GO:0010266) |
3.2 | 12.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
3.2 | 9.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
3.2 | 6.4 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
3.2 | 9.5 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
3.2 | 44.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
3.2 | 3.2 | GO:1901073 | glucosamine-containing compound biosynthetic process(GO:1901073) |
3.1 | 9.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) pulmonary vein morphogenesis(GO:0060577) |
3.1 | 15.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.1 | 12.5 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
3.1 | 9.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
3.1 | 12.4 | GO:0070339 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
3.1 | 12.3 | GO:1990478 | response to ultrasound(GO:1990478) |
3.1 | 9.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
3.1 | 12.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
3.1 | 15.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
3.0 | 9.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
3.0 | 9.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
3.0 | 24.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
3.0 | 9.0 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
3.0 | 12.0 | GO:0019230 | proprioception(GO:0019230) |
3.0 | 12.0 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
3.0 | 8.9 | GO:0045575 | basophil activation(GO:0045575) |
3.0 | 8.9 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
2.9 | 8.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
2.9 | 20.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
2.9 | 14.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
2.9 | 14.4 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
2.9 | 2.9 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
2.9 | 2.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
2.9 | 17.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
2.9 | 20.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
2.9 | 14.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.9 | 14.3 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
2.8 | 8.5 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
2.8 | 56.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
2.8 | 2.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
2.8 | 5.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
2.8 | 16.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
2.8 | 13.8 | GO:0030070 | insulin processing(GO:0030070) |
2.8 | 82.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
2.7 | 5.5 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
2.7 | 10.9 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
2.7 | 8.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
2.7 | 18.8 | GO:0006477 | protein sulfation(GO:0006477) |
2.7 | 13.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
2.7 | 8.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
2.7 | 8.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
2.7 | 5.3 | GO:0071830 | positive regulation of lipoprotein particle clearance(GO:0010986) chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
2.6 | 21.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
2.6 | 5.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
2.6 | 18.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
2.6 | 7.7 | GO:0021874 | Wnt signaling pathway involved in forebrain neuroblast division(GO:0021874) |
2.6 | 7.7 | GO:0071283 | cellular response to iron(III) ion(GO:0071283) |
2.6 | 35.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
2.5 | 2.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
2.5 | 7.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
2.5 | 7.6 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
2.5 | 7.6 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
2.5 | 15.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.5 | 10.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
2.5 | 5.0 | GO:0043366 | beta selection(GO:0043366) |
2.5 | 47.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.5 | 2.5 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
2.5 | 2.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
2.5 | 2.5 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
2.5 | 7.5 | GO:0060166 | olfactory pit development(GO:0060166) |
2.5 | 7.5 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
2.5 | 7.5 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
2.5 | 7.5 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
2.5 | 9.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.5 | 7.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
2.5 | 4.9 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
2.4 | 44.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
2.4 | 17.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
2.4 | 2.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
2.4 | 7.3 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
2.4 | 7.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
2.4 | 2.4 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
2.4 | 38.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
2.4 | 4.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
2.4 | 28.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
2.4 | 9.6 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
2.4 | 14.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.4 | 16.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
2.4 | 9.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.4 | 11.8 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
2.4 | 7.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
2.3 | 2.3 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
2.3 | 7.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.3 | 9.4 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
2.3 | 9.4 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
2.3 | 7.0 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
2.3 | 9.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
2.3 | 11.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
2.3 | 20.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
2.3 | 27.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
2.3 | 6.8 | GO:1901227 | negative regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901227) |
2.3 | 18.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
2.3 | 9.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
2.2 | 11.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
2.2 | 11.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.2 | 13.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
2.2 | 76.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
2.2 | 13.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
2.2 | 26.7 | GO:0006968 | cellular defense response(GO:0006968) |
2.2 | 6.7 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
2.2 | 8.8 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.2 | 6.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.2 | 6.5 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
2.2 | 15.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
2.1 | 64.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
2.1 | 12.8 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
2.1 | 6.4 | GO:1902963 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
2.1 | 8.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
2.1 | 21.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
2.1 | 8.5 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
2.1 | 12.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.1 | 8.4 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
2.1 | 6.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.1 | 6.3 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
2.1 | 4.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.1 | 20.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
2.1 | 20.6 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
2.0 | 4.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
2.0 | 16.3 | GO:0015886 | heme transport(GO:0015886) |
2.0 | 2.0 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
2.0 | 8.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
2.0 | 18.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
2.0 | 14.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
2.0 | 14.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
2.0 | 10.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
2.0 | 6.1 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
2.0 | 4.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
2.0 | 5.9 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
2.0 | 4.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
2.0 | 5.9 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
2.0 | 17.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.0 | 5.9 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
2.0 | 7.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
2.0 | 21.5 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
2.0 | 78.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
1.9 | 11.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.9 | 7.8 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
1.9 | 5.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.9 | 5.8 | GO:0002933 | lipid hydroxylation(GO:0002933) |
1.9 | 21.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.9 | 5.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.9 | 3.8 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
1.9 | 15.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.9 | 3.8 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
1.9 | 5.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.9 | 16.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.9 | 14.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.8 | 22.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
1.8 | 1.8 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
1.8 | 12.8 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
1.8 | 5.5 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.8 | 1.8 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.8 | 9.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.8 | 10.8 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
1.8 | 3.6 | GO:0061056 | sclerotome development(GO:0061056) |
1.8 | 7.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.8 | 1.8 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
1.8 | 7.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
1.8 | 12.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.8 | 3.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
1.8 | 7.0 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
1.8 | 22.8 | GO:0006783 | heme biosynthetic process(GO:0006783) |
1.8 | 10.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.8 | 5.3 | GO:0050755 | chemokine metabolic process(GO:0050755) |
1.7 | 10.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.7 | 3.5 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
1.7 | 6.9 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.7 | 5.1 | GO:1904976 | cellular response to bleomycin(GO:1904976) |
1.7 | 8.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.7 | 5.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.7 | 23.6 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.7 | 10.1 | GO:0010193 | response to ozone(GO:0010193) |
1.7 | 3.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.7 | 3.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.7 | 5.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.7 | 6.7 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.7 | 10.0 | GO:0015677 | copper ion import(GO:0015677) |
1.6 | 4.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.6 | 3.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
1.6 | 6.4 | GO:0051132 | NK T cell activation(GO:0051132) |
1.6 | 20.8 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
1.6 | 4.8 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) positive regulation of macrophage apoptotic process(GO:2000111) |
1.6 | 14.3 | GO:0002934 | desmosome organization(GO:0002934) |
1.6 | 1.6 | GO:1901656 | glycoside transport(GO:1901656) |
1.6 | 4.7 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.6 | 9.4 | GO:0070269 | pyroptosis(GO:0070269) |
1.6 | 4.7 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) |
1.6 | 15.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.6 | 4.7 | GO:2000360 | regulation of binding of sperm to zona pellucida(GO:2000359) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
1.6 | 4.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
1.5 | 4.6 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
1.5 | 1.5 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.5 | 4.6 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
1.5 | 3.1 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
1.5 | 4.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.5 | 6.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
1.5 | 6.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.5 | 4.6 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
1.5 | 4.6 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
1.5 | 12.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.5 | 3.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.5 | 9.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
1.5 | 7.5 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.5 | 10.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.5 | 11.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.5 | 7.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.5 | 4.5 | GO:0071464 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) cellular response to hydrostatic pressure(GO:0071464) |
1.5 | 7.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
1.5 | 3.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.5 | 5.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.5 | 17.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
1.5 | 1.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.5 | 13.1 | GO:0002467 | germinal center formation(GO:0002467) |
1.4 | 4.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.4 | 18.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
1.4 | 2.8 | GO:0071298 | cellular response to L-ascorbic acid(GO:0071298) |
1.4 | 5.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.4 | 9.8 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
1.4 | 5.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
1.4 | 9.8 | GO:0001774 | microglial cell activation(GO:0001774) |
1.4 | 4.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.4 | 4.2 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
1.4 | 2.8 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.4 | 5.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.4 | 16.7 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
1.4 | 16.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.4 | 9.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.4 | 9.5 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
1.4 | 4.1 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
1.4 | 4.1 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
1.4 | 38.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
1.4 | 24.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.3 | 6.7 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
1.3 | 4.0 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
1.3 | 18.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.3 | 4.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.3 | 2.7 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
1.3 | 6.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.3 | 4.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
1.3 | 13.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.3 | 1.3 | GO:0002339 | B cell selection(GO:0002339) |
1.3 | 10.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.3 | 4.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.3 | 2.7 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
1.3 | 3.9 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.3 | 2.6 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.3 | 2.6 | GO:0043134 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
1.3 | 13.0 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
1.3 | 7.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.3 | 3.9 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.3 | 7.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
1.3 | 3.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.3 | 3.9 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
1.3 | 9.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
1.3 | 8.9 | GO:0019395 | fatty acid oxidation(GO:0019395) |
1.3 | 7.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.3 | 3.8 | GO:1903918 | detection of muscle stretch(GO:0035995) regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
1.3 | 5.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
1.3 | 2.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.3 | 6.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.3 | 8.8 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.3 | 6.3 | GO:1904401 | response to Thyroid stimulating hormone(GO:1904400) cellular response to Thyroid stimulating hormone(GO:1904401) |
1.3 | 10.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.3 | 2.5 | GO:0006567 | threonine catabolic process(GO:0006567) |
1.2 | 8.7 | GO:2000018 | regulation of male gonad development(GO:2000018) |
1.2 | 6.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.2 | 5.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
1.2 | 85.7 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
1.2 | 2.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.2 | 4.9 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
1.2 | 24.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
1.2 | 9.8 | GO:0036017 | response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
1.2 | 10.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.2 | 12.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.2 | 14.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.2 | 4.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
1.2 | 2.4 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
1.2 | 3.6 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
1.2 | 9.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.2 | 12.0 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
1.2 | 6.0 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
1.2 | 2.3 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
1.2 | 7.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
1.2 | 9.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.2 | 12.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.2 | 3.5 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.2 | 3.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.1 | 5.7 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.1 | 4.6 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.1 | 6.9 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
1.1 | 4.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.1 | 13.6 | GO:0036065 | fucosylation(GO:0036065) |
1.1 | 4.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.1 | 1.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) specification of axis polarity(GO:0065001) |
1.1 | 4.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.1 | 3.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.1 | 71.3 | GO:0055088 | lipid homeostasis(GO:0055088) |
1.1 | 3.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.1 | 12.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
1.1 | 2.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.1 | 3.3 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
1.1 | 1.1 | GO:2000449 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.1 | 44.3 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
1.1 | 5.5 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
1.1 | 4.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.1 | 9.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.1 | 43.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
1.1 | 2.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
1.1 | 51.8 | GO:0032094 | response to food(GO:0032094) |
1.1 | 17.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.1 | 5.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.1 | 3.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
1.1 | 3.2 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.1 | 4.3 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
1.1 | 1.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.1 | 4.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
1.1 | 3.2 | GO:1901726 | negative regulation of histone deacetylase activity(GO:1901726) |
1.1 | 13.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
1.0 | 4.2 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
1.0 | 7.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.0 | 8.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.0 | 18.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
1.0 | 14.4 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
1.0 | 9.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.0 | 2.1 | GO:0060431 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) primary lung bud formation(GO:0060431) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
1.0 | 4.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) vascular wound healing(GO:0061042) |
1.0 | 2.0 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
1.0 | 2.0 | GO:0009751 | response to salicylic acid(GO:0009751) |
1.0 | 11.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
1.0 | 9.0 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
1.0 | 5.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.0 | 2.0 | GO:0070384 | Harderian gland development(GO:0070384) |
1.0 | 23.8 | GO:0009303 | rRNA transcription(GO:0009303) |
1.0 | 2.0 | GO:0048749 | compound eye development(GO:0048749) |
1.0 | 2.0 | GO:0032264 | IMP salvage(GO:0032264) |
1.0 | 3.0 | GO:1904395 | positive regulation of receptor clustering(GO:1903911) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.0 | 17.7 | GO:0048240 | sperm capacitation(GO:0048240) |
1.0 | 9.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
1.0 | 1.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.0 | 3.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.0 | 5.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.9 | 1.9 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.9 | 2.8 | GO:0043368 | positive T cell selection(GO:0043368) |
0.9 | 9.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.9 | 12.1 | GO:0019835 | cytolysis(GO:0019835) |
0.9 | 10.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.9 | 5.5 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.9 | 1.8 | GO:0038086 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.9 | 7.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.9 | 11.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.9 | 2.7 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) protein localization to vacuolar membrane(GO:1903778) |
0.9 | 3.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.9 | 6.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.9 | 2.7 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.9 | 1.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.9 | 7.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.9 | 3.5 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) mammary gland branching involved in pregnancy(GO:0060745) baculum development(GO:1990375) |
0.9 | 4.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.9 | 1.8 | GO:0018963 | phthalate metabolic process(GO:0018963) |
0.9 | 35.0 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.9 | 4.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.9 | 4.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.9 | 6.9 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.9 | 1.7 | GO:0060290 | transdifferentiation(GO:0060290) |
0.9 | 7.7 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.9 | 1.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.9 | 2.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.9 | 2.6 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.8 | 2.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.8 | 3.4 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.8 | 0.8 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.8 | 4.2 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.8 | 4.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.8 | 2.5 | GO:0009758 | carbohydrate utilization(GO:0009758) |
0.8 | 1.7 | GO:0034368 | macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
0.8 | 5.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.8 | 3.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.8 | 10.0 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.8 | 6.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.8 | 3.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.8 | 38.8 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.8 | 2.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.8 | 3.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.8 | 4.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.8 | 5.6 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.8 | 3.2 | GO:1904044 | response to aldosterone(GO:1904044) |
0.8 | 142.6 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.8 | 4.0 | GO:0033384 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) |
0.8 | 27.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.8 | 2.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.8 | 4.7 | GO:0006983 | ER overload response(GO:0006983) |
0.8 | 7.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.8 | 2.3 | GO:0001562 | response to protozoan(GO:0001562) |
0.8 | 3.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.8 | 6.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.8 | 3.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.8 | 2.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.8 | 27.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.8 | 6.8 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.8 | 2.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.8 | 21.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.8 | 12.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) G2 DNA damage checkpoint(GO:0031572) |
0.8 | 1.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.8 | 4.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.7 | 13.4 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.7 | 7.5 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.7 | 2.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.7 | 4.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.7 | 2.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.7 | 3.6 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.7 | 1.5 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.7 | 2.9 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.7 | 0.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 9.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.7 | 7.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.7 | 20.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.7 | 21.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.7 | 5.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.7 | 8.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.7 | 4.9 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.7 | 3.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 10.3 | GO:0000303 | response to superoxide(GO:0000303) |
0.7 | 2.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.7 | 0.7 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.7 | 1.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.7 | 8.0 | GO:0015816 | glycine transport(GO:0015816) |
0.7 | 2.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.7 | 3.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 2.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.7 | 4.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 3.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.7 | 3.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.7 | 9.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.7 | 6.6 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) S-adenosylmethionine metabolic process(GO:0046500) |
0.7 | 3.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.7 | 16.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.6 | 1.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.6 | 2.6 | GO:0032919 | spermine acetylation(GO:0032919) |
0.6 | 1.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.6 | 5.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.6 | 2.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 1.9 | GO:0046223 | toxin catabolic process(GO:0009407) mycotoxin metabolic process(GO:0043385) mycotoxin catabolic process(GO:0043387) aflatoxin metabolic process(GO:0046222) aflatoxin catabolic process(GO:0046223) secondary metabolite catabolic process(GO:0090487) organic heteropentacyclic compound metabolic process(GO:1901376) organic heteropentacyclic compound catabolic process(GO:1901377) |
0.6 | 3.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 4.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.6 | 17.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.6 | 4.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.6 | 4.9 | GO:0018377 | protein myristoylation(GO:0018377) |
0.6 | 11.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.6 | 5.4 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.6 | 2.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 6.6 | GO:0001945 | lymph vessel development(GO:0001945) |
0.6 | 2.4 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.6 | 0.6 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.6 | 1.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.6 | 2.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.6 | 1.2 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.6 | 5.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.6 | 1.8 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.6 | 2.9 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.6 | 4.0 | GO:0009650 | UV protection(GO:0009650) |
0.6 | 2.8 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.6 | 1.7 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.6 | 2.3 | GO:0072014 | proximal tubule development(GO:0072014) |
0.6 | 4.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.6 | 5.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.6 | 3.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.6 | 24.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.6 | 3.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.5 | 1.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 9.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.5 | 3.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.5 | 5.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 2.7 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.5 | 8.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.5 | 4.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.5 | 3.2 | GO:0014022 | neural plate morphogenesis(GO:0001839) neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) convergent extension involved in organogenesis(GO:0060029) |
0.5 | 5.8 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.5 | 1.0 | GO:0060440 | trachea formation(GO:0060440) regulation of Golgi inheritance(GO:0090170) |
0.5 | 3.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.5 | 13.7 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 2.5 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.5 | 1.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 2.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.5 | 2.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.5 | 5.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.5 | 2.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.5 | 5.8 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.5 | 1.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 3.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
0.5 | 1.0 | GO:2000124 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.5 | 2.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.5 | 5.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.5 | 3.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 41.1 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.5 | 0.9 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.5 | 3.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.5 | 1.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 2.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 0.9 | GO:0035425 | autocrine signaling(GO:0035425) |
0.4 | 32.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.4 | 4.0 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.4 | 4.9 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.4 | 5.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 2.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 4.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 4.8 | GO:0060039 | pericardium development(GO:0060039) |
0.4 | 3.1 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.4 | 3.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 0.8 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.4 | 1.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.4 | 3.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 1.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 1.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 3.3 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.4 | 1.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 2.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.4 | 1.6 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.4 | 0.8 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 1.6 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.4 | 0.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 3.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.4 | 3.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 2.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 0.8 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.4 | 5.4 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.4 | 1.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 1.2 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 5.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.4 | 1.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.4 | 10.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 4.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 1.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.4 | 14.2 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.4 | 1.1 | GO:1901536 | protection of DNA demethylation of female pronucleus(GO:0044726) regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.4 | 4.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.4 | 0.4 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.4 | 0.4 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.4 | 1.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.4 | 1.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 7.2 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.4 | 1.4 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.4 | 1.1 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.3 | 4.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 1.7 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.3 | 1.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 1.0 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.3 | 1.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 1.3 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.3 | 11.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 2.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 0.6 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.3 | 3.8 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 3.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.3 | 2.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 2.8 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.3 | 2.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 6.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.3 | 1.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.3 | 1.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 1.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 0.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 2.4 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 1.5 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 1.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 2.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 1.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 3.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.3 | 1.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.3 | 0.9 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.3 | 0.8 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.3 | 6.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 0.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 1.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 1.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 1.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 1.8 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.3 | 8.7 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.3 | 3.7 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.3 | 1.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 2.0 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 22.8 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.2 | 4.6 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 4.1 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.2 | 3.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.2 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.5 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.2 | 0.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.2 | 1.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 4.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 2.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 0.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 1.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.8 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 1.7 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 3.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 2.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 2.1 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 2.0 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.2 | 1.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 2.3 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 4.4 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 0.8 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.2 | 0.9 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 1.5 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.2 | 1.8 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 1.4 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.2 | 1.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.9 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 2.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 1.4 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 2.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 0.5 | GO:0044597 | polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 4.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.2 | 1.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.3 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.2 | 1.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 2.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 1.0 | GO:0009446 | putrescine metabolic process(GO:0009445) putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 0.6 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.2 | 1.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.4 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.1 | 0.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 1.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 5.1 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 2.0 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 1.3 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.1 | 1.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 2.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.5 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 1.0 | GO:0002716 | negative regulation of natural killer cell mediated immunity(GO:0002716) |
0.1 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.9 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 3.0 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 1.7 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 3.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 1.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.1 | 1.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.8 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.6 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.1 | 5.0 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 1.1 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 0.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.1 | 0.5 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 2.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.3 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.5 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 1.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.5 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.4 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.5 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.0 | 0.2 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 1.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 1.0 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.5 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.2 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.1 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.1 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.6 | 110.2 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
15.3 | 45.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
15.3 | 61.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
13.2 | 66.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
13.0 | 78.1 | GO:0005579 | membrane attack complex(GO:0005579) |
11.9 | 167.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
10.4 | 41.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
10.1 | 1147.9 | GO:0072562 | blood microparticle(GO:0072562) |
10.0 | 29.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
9.2 | 46.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
7.8 | 23.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
7.3 | 29.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
6.4 | 19.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
6.4 | 197.9 | GO:0042588 | zymogen granule(GO:0042588) |
5.9 | 23.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
5.8 | 5.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
5.7 | 45.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
5.2 | 15.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
4.7 | 9.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
4.6 | 27.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
4.4 | 8.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
4.4 | 43.9 | GO:0045179 | apical cortex(GO:0045179) |
4.2 | 4.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
4.1 | 12.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
4.0 | 28.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
4.0 | 15.9 | GO:0019814 | immunoglobulin complex(GO:0019814) |
3.6 | 10.8 | GO:0032398 | MHC class Ib protein complex(GO:0032398) |
3.6 | 14.3 | GO:0034774 | secretory granule lumen(GO:0034774) |
3.5 | 56.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
3.5 | 13.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
3.4 | 3.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.4 | 6.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
3.4 | 44.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
3.3 | 6.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
3.2 | 252.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
3.0 | 21.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
3.0 | 9.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
2.9 | 109.7 | GO:0001772 | immunological synapse(GO:0001772) |
2.9 | 8.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.8 | 14.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.8 | 31.1 | GO:0034364 | plasma lipoprotein particle(GO:0034358) high-density lipoprotein particle(GO:0034364) lipoprotein particle(GO:1990777) |
2.8 | 8.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
2.8 | 19.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
2.8 | 60.8 | GO:0031528 | microvillus membrane(GO:0031528) |
2.6 | 7.9 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
2.6 | 13.1 | GO:0097413 | Lewy body(GO:0097413) |
2.6 | 13.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.6 | 7.7 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
2.5 | 7.6 | GO:0070421 | DNA ligase III-XRCC1 complex(GO:0070421) |
2.4 | 4.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
2.4 | 12.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.3 | 14.1 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
2.3 | 4.7 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
2.3 | 41.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
2.3 | 50.5 | GO:0030057 | desmosome(GO:0030057) |
2.3 | 18.2 | GO:0000796 | condensin complex(GO:0000796) |
2.3 | 11.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.1 | 14.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
2.1 | 8.4 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
2.1 | 6.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
2.1 | 28.9 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
2.1 | 12.3 | GO:0005796 | Golgi lumen(GO:0005796) |
2.0 | 146.5 | GO:0045095 | keratin filament(GO:0045095) |
2.0 | 4.1 | GO:0036398 | TCR signalosome(GO:0036398) |
2.0 | 15.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.9 | 27.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.9 | 7.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.9 | 7.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.9 | 7.4 | GO:0036156 | inner dynein arm(GO:0036156) |
1.8 | 40.6 | GO:0042629 | mast cell granule(GO:0042629) |
1.8 | 5.5 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
1.8 | 31.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
1.8 | 5.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.8 | 7.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.8 | 7.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.7 | 20.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
1.7 | 15.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.7 | 16.7 | GO:0005771 | multivesicular body(GO:0005771) |
1.6 | 8.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.6 | 6.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.6 | 14.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.6 | 6.4 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
1.5 | 10.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.5 | 12.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.5 | 13.4 | GO:0005915 | zonula adherens(GO:0005915) |
1.5 | 4.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.5 | 5.9 | GO:0035339 | SPOTS complex(GO:0035339) |
1.5 | 10.3 | GO:0031415 | NatA complex(GO:0031415) |
1.5 | 5.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
1.4 | 5.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.4 | 2.9 | GO:0043511 | inhibin complex(GO:0043511) |
1.4 | 2.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
1.3 | 16.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.3 | 9.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.3 | 5.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.3 | 6.3 | GO:1903767 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
1.3 | 7.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.3 | 16.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.2 | 6.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.2 | 4.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.2 | 9.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.2 | 10.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
1.2 | 4.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.2 | 3.5 | GO:0044299 | C-fiber(GO:0044299) |
1.1 | 5.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.1 | 4.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.1 | 9.0 | GO:0005614 | interstitial matrix(GO:0005614) |
1.1 | 5.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.1 | 7.8 | GO:0001739 | sex chromatin(GO:0001739) |
1.1 | 12.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.1 | 7.6 | GO:0044194 | cytolytic granule(GO:0044194) |
1.1 | 5.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.1 | 24.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
1.1 | 7.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.0 | 36.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
1.0 | 3.1 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
1.0 | 5.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.0 | 4.0 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
1.0 | 128.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.0 | 6.7 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.9 | 713.1 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.9 | 2.7 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.9 | 3.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.9 | 14.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.9 | 2.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.9 | 2.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.9 | 5.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.9 | 16.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.9 | 11.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.9 | 45.2 | GO:0005811 | lipid particle(GO:0005811) |
0.9 | 2.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.8 | 8.5 | GO:0044754 | autolysosome(GO:0044754) |
0.8 | 2.5 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.8 | 2.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.8 | 7.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.8 | 3.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.8 | 81.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.8 | 6.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.8 | 51.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.8 | 986.8 | GO:0005615 | extracellular space(GO:0005615) |
0.8 | 3.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.7 | 17.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.7 | 8.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.7 | 33.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.7 | 2.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.7 | 147.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.7 | 2.8 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 11.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.7 | 2.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.7 | 2.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 23.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.7 | 7.5 | GO:0042611 | MHC protein complex(GO:0042611) |
0.7 | 11.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.7 | 5.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.6 | 6.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 3.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.6 | 13.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.6 | 26.6 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.6 | 1.8 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.6 | 22.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.6 | 55.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.6 | 5.9 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.6 | 2.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.6 | 2.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 1.6 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
0.5 | 3.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.5 | 5.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 6.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.5 | 3.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 9.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.4 | 2.2 | GO:0034455 | t-UTP complex(GO:0034455) |
0.4 | 24.6 | GO:0005840 | ribosome(GO:0005840) |
0.4 | 1.7 | GO:0035363 | histone locus body(GO:0035363) |
0.4 | 6.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 2.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 38.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 4.9 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.4 | 3.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.4 | 3.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 6.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 2.3 | GO:0070449 | elongin complex(GO:0070449) |
0.4 | 3.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 4.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.4 | 2.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) nuclear pore nuclear basket(GO:0044615) |
0.4 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 4.4 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 3.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 1.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 1.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 1.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 1.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 1.1 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.3 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 3.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.3 | 1.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 10.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 59.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 1.5 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 2.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 8.0 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 3.0 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 3.9 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 4.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 2.1 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 2.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 3.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 1.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) prespliceosome(GO:0071010) |
0.1 | 5.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 2.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 38.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 7.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 1.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 2.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 1.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 1.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 9.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 1.0 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
32.4 | 97.1 | GO:0031714 | C5a anaphylatoxin chemotactic receptor binding(GO:0031714) |
25.2 | 75.6 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
23.5 | 70.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
21.0 | 63.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
20.8 | 145.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
15.3 | 45.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
15.0 | 45.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
14.5 | 43.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
13.9 | 41.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
13.5 | 67.3 | GO:0019862 | IgA binding(GO:0019862) |
12.1 | 48.4 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
11.6 | 57.9 | GO:0005550 | pheromone binding(GO:0005550) |
11.5 | 46.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
10.8 | 32.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
10.4 | 83.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
10.1 | 30.3 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
10.1 | 412.6 | GO:0070330 | aromatase activity(GO:0070330) |
9.6 | 38.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
9.4 | 18.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
9.1 | 63.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
9.1 | 90.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
9.0 | 27.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
8.9 | 134.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
8.6 | 68.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
8.5 | 42.5 | GO:0005499 | vitamin D binding(GO:0005499) |
8.5 | 34.0 | GO:0008265 | Mo-molybdopterin cofactor sulfurase activity(GO:0008265) |
8.4 | 25.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
8.4 | 210.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
8.2 | 40.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
7.9 | 31.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
7.9 | 134.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
7.9 | 78.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
7.8 | 31.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
7.8 | 54.6 | GO:0032052 | bile acid binding(GO:0032052) |
7.8 | 101.3 | GO:1990405 | protein antigen binding(GO:1990405) |
7.7 | 161.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
7.6 | 30.6 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
7.6 | 37.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
7.6 | 37.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
7.4 | 111.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
7.4 | 89.0 | GO:0001848 | complement binding(GO:0001848) |
7.3 | 51.2 | GO:0035375 | zymogen binding(GO:0035375) |
7.2 | 36.1 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
7.2 | 28.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
7.1 | 78.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
7.1 | 35.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
7.0 | 42.2 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
6.8 | 34.2 | GO:0004103 | choline kinase activity(GO:0004103) |
6.7 | 208.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
6.7 | 33.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
6.7 | 33.3 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
6.6 | 19.7 | GO:0004359 | glutaminase activity(GO:0004359) |
6.5 | 39.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
6.5 | 19.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
6.5 | 32.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
6.4 | 6.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
6.3 | 19.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
6.3 | 31.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
6.3 | 37.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
6.2 | 242.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
6.1 | 30.4 | GO:0005534 | galactose binding(GO:0005534) |
6.1 | 24.3 | GO:0034618 | arginine binding(GO:0034618) |
6.0 | 53.9 | GO:0015232 | heme transporter activity(GO:0015232) |
5.9 | 29.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
5.9 | 23.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
5.8 | 28.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
5.7 | 17.0 | GO:0004522 | ribonuclease A activity(GO:0004522) |
5.7 | 22.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
5.6 | 16.9 | GO:0008458 | carnitine O-octanoyltransferase activity(GO:0008458) O-octanoyltransferase activity(GO:0016414) |
5.5 | 631.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
5.5 | 16.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
5.5 | 38.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
5.4 | 5.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
5.3 | 42.6 | GO:0008430 | selenium binding(GO:0008430) |
5.3 | 26.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
5.2 | 10.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
5.0 | 110.0 | GO:0019825 | oxygen binding(GO:0019825) |
4.9 | 14.8 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
4.8 | 43.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
4.8 | 14.4 | GO:0004040 | amidase activity(GO:0004040) |
4.7 | 14.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
4.7 | 9.3 | GO:0055100 | adiponectin binding(GO:0055100) |
4.6 | 13.9 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
4.5 | 40.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
4.5 | 9.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
4.4 | 8.8 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
4.2 | 12.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
4.2 | 16.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
4.0 | 28.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
4.0 | 35.8 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
3.9 | 15.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
3.9 | 19.5 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
3.9 | 15.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
3.8 | 11.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
3.8 | 72.6 | GO:0008199 | ferric iron binding(GO:0008199) |
3.8 | 33.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
3.7 | 11.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
3.7 | 40.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
3.7 | 11.1 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
3.7 | 51.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
3.6 | 35.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
3.6 | 14.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
3.6 | 7.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
3.5 | 14.2 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
3.5 | 10.5 | GO:0019961 | interferon binding(GO:0019961) |
3.5 | 10.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
3.5 | 34.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
3.5 | 10.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
3.4 | 10.3 | GO:0002054 | nucleobase binding(GO:0002054) |
3.4 | 10.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
3.4 | 10.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
3.4 | 6.7 | GO:0038100 | nodal binding(GO:0038100) |
3.4 | 10.1 | GO:0070012 | oligopeptidase activity(GO:0070012) |
3.3 | 10.0 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
3.3 | 53.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
3.3 | 26.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
3.3 | 19.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.3 | 6.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
3.3 | 156.7 | GO:0038024 | cargo receptor activity(GO:0038024) |
3.3 | 16.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
3.2 | 9.7 | GO:0070404 | NADH binding(GO:0070404) |
3.2 | 19.3 | GO:0050692 | DBD domain binding(GO:0050692) |
3.1 | 9.4 | GO:0048030 | disaccharide binding(GO:0048030) |
3.1 | 37.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
3.1 | 6.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
3.1 | 12.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
3.0 | 27.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
3.0 | 27.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
3.0 | 9.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
3.0 | 3.0 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
3.0 | 30.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.0 | 57.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
3.0 | 11.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
3.0 | 17.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.9 | 11.6 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
2.9 | 23.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.9 | 37.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.8 | 17.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
2.8 | 17.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
2.8 | 5.6 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
2.8 | 8.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
2.7 | 10.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
2.7 | 16.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
2.7 | 10.7 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
2.7 | 10.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
2.7 | 8.0 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
2.7 | 5.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
2.7 | 10.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.6 | 562.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
2.6 | 10.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.6 | 13.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
2.6 | 18.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
2.6 | 5.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.6 | 23.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
2.5 | 12.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
2.5 | 20.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
2.5 | 12.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
2.5 | 2.5 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
2.5 | 67.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
2.5 | 2.5 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
2.5 | 7.5 | GO:0047522 | 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
2.5 | 7.4 | GO:0035877 | death effector domain binding(GO:0035877) |
2.5 | 7.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
2.5 | 9.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
2.5 | 9.8 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
2.4 | 7.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.4 | 7.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
2.4 | 16.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
2.4 | 7.2 | GO:0042806 | fucose binding(GO:0042806) |
2.4 | 28.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.4 | 9.5 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
2.3 | 7.0 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.3 | 14.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.3 | 9.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
2.3 | 7.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
2.3 | 4.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
2.3 | 11.6 | GO:0046790 | virion binding(GO:0046790) |
2.3 | 13.8 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
2.3 | 6.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.3 | 9.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.3 | 34.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.2 | 6.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
2.2 | 8.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.2 | 12.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
2.1 | 6.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
2.1 | 8.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
2.1 | 12.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
2.1 | 196.4 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
2.1 | 6.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
2.0 | 10.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
2.0 | 6.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
2.0 | 34.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
2.0 | 9.9 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
2.0 | 5.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
1.9 | 7.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.9 | 7.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.9 | 13.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.9 | 17.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.9 | 254.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
1.9 | 46.9 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
1.9 | 13.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.9 | 7.5 | GO:0019166 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.8 | 5.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
1.8 | 9.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.8 | 5.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.8 | 14.5 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.8 | 26.9 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
1.8 | 21.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.8 | 89.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.8 | 5.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
1.7 | 22.4 | GO:0003796 | lysozyme activity(GO:0003796) |
1.7 | 31.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
1.7 | 6.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.7 | 6.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
1.7 | 10.0 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.6 | 6.5 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
1.6 | 16.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.6 | 6.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.6 | 3.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.6 | 24.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.6 | 11.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.6 | 6.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.6 | 3.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.6 | 14.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.6 | 4.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.6 | 12.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.6 | 32.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.6 | 6.2 | GO:0030172 | troponin C binding(GO:0030172) |
1.5 | 10.8 | GO:0003896 | DNA primase activity(GO:0003896) |
1.5 | 17.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.5 | 6.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.5 | 7.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.5 | 27.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.5 | 5.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.5 | 24.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
1.5 | 32.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.5 | 5.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.4 | 4.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.4 | 11.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.4 | 27.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
1.4 | 7.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.4 | 14.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.4 | 4.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.4 | 11.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.4 | 2.8 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
1.4 | 7.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.4 | 11.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.4 | 40.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.4 | 5.4 | GO:0002046 | opsin binding(GO:0002046) |
1.4 | 4.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
1.4 | 2.7 | GO:0032190 | acrosin binding(GO:0032190) |
1.3 | 14.7 | GO:0070402 | NADPH binding(GO:0070402) |
1.3 | 9.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.3 | 13.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.3 | 2.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
1.3 | 5.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.3 | 3.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.3 | 2.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.2 | 3.7 | GO:0046979 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.2 | 2.5 | GO:0043559 | insulin binding(GO:0043559) |
1.2 | 6.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.2 | 2.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.2 | 4.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.2 | 15.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
1.2 | 7.2 | GO:0070728 | leucine binding(GO:0070728) |
1.2 | 5.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.2 | 9.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.2 | 9.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.2 | 10.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.2 | 29.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.2 | 5.8 | GO:0010181 | FMN binding(GO:0010181) |
1.1 | 14.9 | GO:0004601 | peroxidase activity(GO:0004601) |
1.1 | 4.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.1 | 3.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.1 | 8.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.1 | 4.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.1 | 28.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.1 | 9.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.1 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
1.1 | 1.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
1.1 | 8.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.1 | 3.2 | GO:0030626 | U12 snRNA binding(GO:0030626) |
1.1 | 2.1 | GO:0030984 | kininogen binding(GO:0030984) |
1.1 | 6.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.1 | 3.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 4.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.0 | 5.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.0 | 19.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.0 | 2.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.0 | 6.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
1.0 | 13.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.0 | 9.2 | GO:0016208 | AMP binding(GO:0016208) |
1.0 | 9.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.0 | 12.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.0 | 32.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.0 | 4.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
1.0 | 2.9 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
1.0 | 20.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.0 | 232.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.9 | 19.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.9 | 1.9 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.9 | 2.8 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.9 | 6.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.9 | 12.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.9 | 5.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.9 | 3.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.9 | 4.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.9 | 3.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.9 | 1.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.9 | 3.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.9 | 3.5 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.9 | 19.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.9 | 1.7 | GO:0031763 | galanin receptor binding(GO:0031763) type 2 galanin receptor binding(GO:0031765) type 3 galanin receptor binding(GO:0031766) |
0.9 | 9.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.9 | 6.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.9 | 4.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.9 | 2.6 | GO:0019809 | spermidine binding(GO:0019809) |
0.8 | 66.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.8 | 5.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.8 | 4.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.8 | 27.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.8 | 2.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 11.6 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.8 | 6.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.8 | 4.0 | GO:0070697 | activin receptor binding(GO:0070697) |
0.8 | 15.4 | GO:0050661 | NADP binding(GO:0050661) |
0.8 | 4.0 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.8 | 8.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.8 | 4.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.8 | 6.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 31.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.8 | 3.0 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.8 | 3.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 1.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.7 | 18.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.7 | 2.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.7 | 5.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 0.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.7 | 3.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 3.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.7 | 3.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.7 | 5.6 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 1.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.7 | 11.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.7 | 4.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.7 | 13.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.7 | 2.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 12.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.7 | 4.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 1.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.6 | 4.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 3.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 2.6 | GO:0043404 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.6 | 27.9 | GO:0020037 | heme binding(GO:0020037) |
0.6 | 4.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 3.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 11.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 8.7 | GO:0015250 | water channel activity(GO:0015250) |
0.6 | 8.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.6 | 2.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.6 | 1.8 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.6 | 1.2 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
0.6 | 1.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.6 | 2.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.6 | 1.8 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.6 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 6.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 2.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 1.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 6.6 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.5 | 10.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 2.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 2.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 2.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 4.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.5 | 2.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.5 | 133.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 10.7 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 1.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.5 | 2.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.5 | 1.5 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.5 | 2.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.5 | 2.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 18.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.5 | 1.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.5 | 4.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 4.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 2.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 2.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.5 | 2.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 10.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.3 | GO:0000991 | transcription factor activity, core RNA polymerase II binding(GO:0000991) |
0.4 | 1.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 2.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 1.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 16.7 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 5.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 11.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 4.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 12.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 4.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 1.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.4 | 4.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 14.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.4 | 131.0 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.4 | 7.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 1.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 2.0 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 4.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 1.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 1.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 2.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 3.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 0.9 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.3 | 16.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 1.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 2.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 5.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 6.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 2.2 | GO:0052834 | inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 3.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 1.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 1.3 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.3 | 1.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 5.5 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 19.1 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 15.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 4.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 8.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 3.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 5.6 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.7 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.2 | 0.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 1.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 2.3 | GO:0015924 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 1.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 0.6 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 1.0 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
0.2 | 0.4 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.2 | 3.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 6.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 2.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 4.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 5.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 2.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.2 | GO:0001635 | calcitonin gene-related peptide receptor activity(GO:0001635) |
0.1 | 3.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 10.5 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.7 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 5.0 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.2 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 0.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 1.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 2.8 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 1.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 1.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.5 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.4 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 2.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.3 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 7.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.2 | 253.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
6.4 | 19.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
6.3 | 69.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
4.4 | 241.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
3.5 | 147.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
3.4 | 57.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.9 | 667.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
2.3 | 87.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.2 | 31.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
2.1 | 46.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
2.1 | 59.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.9 | 30.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.9 | 51.5 | PID EPO PATHWAY | EPO signaling pathway |
1.9 | 38.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.6 | 55.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.4 | 33.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.4 | 31.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.4 | 15.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.4 | 8.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.4 | 15.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.3 | 37.3 | PID BCR 5PATHWAY | BCR signaling pathway |
1.3 | 36.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.2 | 11.1 | PID IGF1 PATHWAY | IGF1 pathway |
1.2 | 7.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.2 | 5.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.2 | 18.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.1 | 8.0 | PID ALK2 PATHWAY | ALK2 signaling events |
1.1 | 47.3 | PID AURORA B PATHWAY | Aurora B signaling |
1.1 | 6.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.1 | 76.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.0 | 10.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.0 | 42.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.0 | 40.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.0 | 2.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.9 | 2.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 12.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.8 | 13.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.8 | 17.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.7 | 1.5 | PID MYC PATHWAY | C-MYC pathway |
0.7 | 34.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.7 | 56.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.7 | 28.1 | PID BMP PATHWAY | BMP receptor signaling |
0.7 | 16.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.7 | 8.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 7.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.6 | 10.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.6 | 19.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.6 | 8.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.5 | 2.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 29.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 81.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 7.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 16.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 4.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.5 | 16.3 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 13.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.5 | 3.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 7.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 12.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 2.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 16.0 | PID E2F PATHWAY | E2F transcription factor network |
0.4 | 20.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 13.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 7.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 8.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 5.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 7.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 2.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 8.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 0.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 3.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 11.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 2.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 5.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 2.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 8.0 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.7 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.8 | 13.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
13.7 | 136.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
13.3 | 265.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
12.0 | 36.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
11.5 | 160.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
10.5 | 63.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
9.6 | 172.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
9.2 | 175.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
7.0 | 69.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
7.0 | 222.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
6.7 | 113.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
6.3 | 94.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
5.9 | 70.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
5.4 | 80.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
5.1 | 131.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
5.0 | 5.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
4.8 | 43.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
4.6 | 22.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
3.9 | 31.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
3.9 | 54.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
3.8 | 46.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
3.6 | 7.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
3.6 | 49.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
3.5 | 14.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
3.5 | 27.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
3.5 | 100.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
3.4 | 6.7 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
3.3 | 43.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
3.3 | 26.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
3.3 | 36.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
3.2 | 45.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.0 | 14.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
2.9 | 44.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
2.8 | 22.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
2.8 | 142.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
2.7 | 21.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
2.7 | 18.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
2.5 | 42.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
2.4 | 48.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
2.4 | 97.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.3 | 27.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
2.1 | 22.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
2.1 | 32.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
2.0 | 26.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
2.0 | 4.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
2.0 | 25.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.9 | 115.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.9 | 84.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.8 | 58.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.7 | 8.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.7 | 18.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.7 | 20.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.6 | 64.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.6 | 27.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.6 | 17.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.5 | 7.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
1.5 | 28.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.5 | 15.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.5 | 17.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.4 | 47.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.4 | 209.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.4 | 15.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.4 | 23.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.4 | 8.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.3 | 18.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.3 | 17.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.3 | 5.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.3 | 144.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
1.2 | 21.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
1.2 | 22.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.2 | 9.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.1 | 10.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.1 | 7.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.1 | 26.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.1 | 16.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.1 | 50.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.0 | 2.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.0 | 3.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.0 | 18.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.9 | 9.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.9 | 13.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.9 | 4.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.9 | 6.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.9 | 21.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.9 | 15.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.9 | 2.7 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.9 | 6.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.9 | 2.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.9 | 12.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.9 | 4.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.8 | 91.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.8 | 10.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.8 | 3.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.8 | 6.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.8 | 9.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.8 | 10.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.7 | 17.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.7 | 8.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 9.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 8.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.7 | 11.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.7 | 5.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.6 | 7.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 1.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 23.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 10.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 8.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.6 | 10.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 11.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.6 | 26.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 9.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 9.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.6 | 5.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.6 | 5.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.5 | 1.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 3.3 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.5 | 18.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 14.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 9.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.5 | 11.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 26.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.5 | 10.8 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.5 | 10.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 3.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 16.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 6.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 1.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 4.0 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.4 | 2.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 2.2 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.3 | 10.3 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.3 | 3.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 4.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 6.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 6.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.3 | 3.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 5.2 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.3 | 1.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 4.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 10.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 4.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 0.8 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 4.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 1.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 7.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 5.6 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.2 | 3.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 2.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 3.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 10.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 3.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 3.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 1.2 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 2.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 0.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 4.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |